Status:
RECRUITING
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
Lead Sponsor:
Sohag University
Conditions:
Beta-Thalassemia
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
The β-thalassemias are a group of inherited disorders of hemoglobin (Hb) synthesis characterized by chronic anemia of varying severity. The degree of anemia relies on several genetic and environmental...
Eligibility Criteria
Inclusion
- confirmed diagnosis of beta thalassemia major or intermedia,
- Age between 2-18 years,
- Receiving regular blood transfusions every 2-5 weeks
- Prescribed oral iron chelation therapy with deferasirox for at least 1 year prior to enrollment.
Exclusion
- Age less than 2 years and more than 18 years
- Any cause of blood transfusion other than beta Thalassemia
- Patients on deferoxamine
Key Trial Info
Start Date :
July 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 14 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06568926
Start Date
July 14 2024
End Date
July 14 2025
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt